There are exciting new developments in several areas of atrial fibrillation (AF) management
that carry the hope of improving outcomes in AF patients. This paper is an executive …

While management of atrial fibrillation (AF) patients is improved by guideline-conform
application of anticoagulant therapy, rate control, rhythm control, and therapy of …

Atrial fibrillation (AF) causes important mortality and morbidity on a population-level. So far,
we do not have the means to prevent AF or AF-related complications adequately. Therefore …

Atrial fibrillation (AF) is a condition of genuine clinical concern. This arrhythmia increases
patient morbidity and mortality, most notably due to stroke, thromboembolism and heart …

Atrial fibrillation (AF) is already an endemic disease, and its prevalence is soaring, due to
both an increasing incidence of the arrhythmia and an age-related increase in its …

There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF).
The population with AF is expected to expand considerably and yet, apart from …

Atrial fibrillation (AF) is the most common clinical arrhythmia and is associated with
increased morbidity and mortality. There is growing evidence that numerous cardiovascular …

Atrial fibrillation (AF) is an extremely common clinical problem with an important population
morbidity and mortality burden. The management of AF is complex and fraught with many …

Atrial fibrillation (AF) is the most common arrhythmia with a substantial effect on individual
morbidity and mortality as well as healthcare expenditure. The management of AF is …

At least 30 million people worldwide carry a diagnosis of atrial fibrillation (AF), and many
more suffer from undiagnosed, subclinical, or 'silent'AF. Atrial fibrillation-related …